Skip to content

Effect of the Azilsartan for sleep disordered breathing with hypertension

Effect of the Azilsartan for sleep disordered breathing with hypertension - Effect of the Azilsartan for sleep disordered breathing with hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014901
Enrollment
60
Registered
2014-09-20
Start date
2014-09-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disordered breathing with hypertension

Interventions

AT1 receptor blocker:Azilsaratan no medication

Sponsors

Fujita Health University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: sleep disordered breathing with hypertension

Exclusion criteria

Exclusion criteria: pregnancy bilateral renal artery stenosis hyperpottasium

Design outcomes

Primary

MeasureTime frame
Effect of Azilsartan on sympathetic nerve activity in sleep disordered breathing with hypertension

Secondary

MeasureTime frame
Effect of Azilsartan on Blood Pressure in sleep disordered breathing with hypertension

Countries

Japan

Contacts

Public ContactYoshihiro Sobue

Fujita Health University cardiology

sobue@fujita-hu.ac.jp0562-93-2312

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026